The funding scramble: countries desperately seek HIV finance solutions
Does six-monthly PrEP have a future following the collapse of global HIV funding?
The US cuts challenge African funders and governments to provide new models of PrEP access
US funding cuts cause immediate drops in numbers testing and on HIV treatment
Scaling back PEPFAR will leave 700,000 without PrEP and cause 6700 new HIV infections within a year
“We will not go back!”: a powerful, resolute response to funding cuts at IAS 2025
HIV testing requirements must be simplified for injectable PrEP to have a future
PEPFAR study shows the deadly impact of stopping children’s HIV treatment
Radical changes in US policy threaten two decades’ progress in HIV
